Presenters at the Third International Conference on Cell Therapy for Cardiovascular Diseases reported the most recent clinical trial results of cell-based treatments for congestive heart failure involving both bone marrow- and muscle-derived progenitor cells.
- Comment
- Reblog
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Fluent in Science 